Abdullah TUNCEZ, Şeref ULUCAN, Hüseyin KATLANDUR, Ahmet KESER, Zeynettin KAYA

Reoperative coronary artery bypass grafting

%11,4'e varan oranlarda yüksek mortalite ile birliktedir. Koroner arter bypass greftleme (KABG) operasyonu geçiren hastaların %10-20'sinin 10 yıl içinde yeniden KABG operasyonuna ihtiyaç duyacakları tahmin edilmektedir. Yüksek ameliyat riskleri nedeniyle KABG öyküsü olan ve akut koroner sendromu ile gelen hastalar için perkutan koroner girişimler önerilen tedavi yöntemi olarak ortaya çıkmıştır. Burada yeniden KABG operasyonu ihtiyacı doğan bir hastada uyguladığımız perkutan koroner girişimi sunduk

Koroner arter bypass greftlemesi yeniden operasyonu

(redo CABG) operation is associated with a high rate of mortality up to 11.4%. It has been estimated that 10-20% of patients with history of coronary artery bypass grafting (CABG) operation need redo CABG operation within 10 years. Due to high operation risk percutaneous coronary interventions have emerged as the preferred treatment for the patients with a history of CABG operation and presenting with acute coronary syndrome. Here, we reported percutaneous coronary intervention in a patient needed redo CABG operation. J Clin Exp Invest 2013; 4 (3): 380-382

PDF

___

Beldi G, Bosshard A, Hess OM, et al. Transit time flow measurement: experimental validation and com- parison of three different systems. Ann Thorac Surg 2000;70:212-217.
Lytle BW, Loop FD. Superiority of bilateral internal tho- racic artery grafting; it's been a long time comin. Cir- culation 2001;104:2152-2154.
Shahabuddin S, Ansari JA, Siddiqui FJ, et al. Redo coronary artery surgery; early and intermediate out- comes from a tertiary care hospital in a developing country. J Pak Med Assoc 2011;61:31-35.
Morrison DA, Sethi G, Sacks J, et al. Percutaneous coronary intervention versus repeat bypass surgery for patients with medically refractory myocardial isch- emia: AWESOME randomized trial and registry ex- perience with post-CABG patients. J Am Coll Cardiol 2002;40:1951-1954.
Yazdani SK, Farb A, Nakano M, et al. Pathology of drug-eluting versus bare-metal stents in saphenous vein bypass graft lesions. JACC Cardiovasc Interv 2012;5:666-667.